|
An event of dizziness, chest pain, hypotension, circumferential pericardial effusion and cardiac tamponade were reported two days post amulet device implant.While in the hospital the patient decompensated further and went into cardiac arrest requiring cardiopulmonary resuscitation (cpr).A pericardiocentesis was performed while the patient was coding.However, the patient expired and the cause of death was reported as pericardial effusion.The device remained implanted and will not return to abbott for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the cine review performed at abbott, the final amulet device position appeared to be deep into the laa.A deep amulet implant into the laa may have increased the risk for developing a pericardial effusion.Based on medical review, the patient death appears to be related to post-procedure bleeding into pericardial space with development of cardiac tamponade.The cause for the bleeding could not be determined.It is possible that bleeding may be result of micro-perforation of the laa and/or injury to the pulmonary artery.However, this could not be confirmed.A pericardial effusion is a known potential adverse event following laao.The reported patient effects of angina, movement disorder, pericardial effusion, cardiac tamponade, hypotension, cardiac arrest and death appears to be a cascading effect.The reported hospitalization and unexpected medical intervention were result of case-specific circumstance as pericardiocentesis was performed for perforation and resuscitation was required due to cardiac arrest.There were no complaints associated with any other devices from the lot.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
|